Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

David Gomez-Almaguer, MD, Olga Cantu-Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, MD, Jose Carlos Jaime-Perez, MD PhD, Luz C. Tarin-Arzaga, MD, Monica Sanchez Cardenas, MD, Rosa Elena Lozano-Morales, MD, Guillermo Sotomayor Duque, MD, Daniela Cárdenas-Araujo, MD, Andres Gomez-de Leon, MD, Paola Santana-Hernandez, Perla Rocío Colunga-Pedraza, MD

Blood (2016) 128 (22): 1369.

https://doi.org/10.1182/blood.V128.22.1369.1369

Published: 2016

Journal Articles

Low Dose Rituximab and Plasma Exchange As Frontline Therapy for Patients with Thrombotic Thrombocytopenic Purpura

Alberto Vazquez Mellado, MD, Olga Graciela Cantu-Rodriguez, MD, Myrna Pequeño-Luévano, MD, Laura Villarreal-Martínez, MD, José Carlos Jaime-Pérez, MD, Andres Gomez-De-Leon, MD, Oscar Gonzalez-Llano, MD PhD, Perla Colunga-Pedraza, MD, Guillermo Sotomayor-Duque, David Gomez-Almaguer, MD

Blood (2015) 126 (23): 2257.

https://doi.org/10.1182/blood.V126.23.2257.2257

Published: 2015

Journal Articles

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Olga Graciela Cantú-Rodríguez, MD, Fernando Lavalle-Gonzalez, MD, Miguel Angel Herrera-Rojas, MD, Cesar H Gutiérrez-Aguirre, MD, Consuelo Mancías-Guerra, MD, Jose Carlos Jaime-Pérez, MD, Oscar Gonzalez-Llano, MD, Alfonso Zapata-Garrido, MD, Jesus Zacarias Villarreal-Perez, MD, David Gomez-Almaguer, MD

Blood (2014) 124 (21): 1191.

https://doi.org/10.1182/blood.V124.21.1191.1191

Published: 2014

Journal Articles

Eltrombopag and High-Dose Dexamethasone As First Line Treatment For ITP

David Gomez-Almaguer, MD, Miguel Angel Herrera-Rojas, MD, Andres Gomez-de Leon, MD, Olga Graciela Cantú-Rodríguez, MD, Cesar H Gutiérrez-Aguirre, MD, Jose Carlos Jaime-Pérez, MD, Luz C. Tarin-Arzaga, MD, Guillermo J. Ruiz-Arguelles, MD, FRCP (Glasg), MACP, Jesus Hernandez-Reyes, MD

Blood (2013) 122 (21): 3544.

https://doi.org/10.1182/blood.V122.21.3544.3544

Published: 2013

Journal Articles

Prevalence Of FLT3 Mutations In Acute Myeloid Leukemia: A Multicenter Latin America Study

Jorge Cuervo-Sierra, MD, David Gómez-Almaguer, MD, Jose Carlos Jaime-Pérez, MD, Ramón Alejandro Martínez-Hernández, MD, Ricardo David García Sepúlveda, MD, Mónica Sánchez-Cárdenas, MD, Rocio Ortiz-López, MD, Gregorio Ignacio-Ibarra, MD, Gabriel Muciño-Hernández, MD, Rosa Maria Arana-Trejo, MD, Guillermo J. Ruiz-Arguelles, MD, FRCP (Glasg), MACP, Guillermo J. Ruiz-Delgado, MD, Julia Lutz-Prestno, MD, Angélica Jiménez-Mejía, MD, Gonzalo Vásquez-Palacio, Biol. Esp. Msc., Mauricio Camargo-Guerrero, MD

Blood (2013) 122 (21): 4979.

https://doi.org/10.1182/blood.V122.21.4979.4979

Published: 2013

Journal Articles

Low-Dose Nilotinib and Imatinib Combination In CML Patients, With Failure, Suboptimal Response Or Treatment Intolerance To First Line Imatinib Treatment. A Pilot Study

David Gomez-Almaguer, MD, Roxana Saldaña-Vázquez, MD, Olga Graciela Cantú-Rodríguez, MD, Cesar H Gutiérrez-Aguirre, MD, Jose Carlos Jaime-Pérez, MD, Luz C. Tarin-Arzaga, MD

Blood (2013) 122 (21): 4034.

https://doi.org/10.1182/blood.V122.21.4034.4034

Published: 2013

Journal Articles

Alemtuzumab and Rituximab in the treatment of refractory autoimmune Cytopenias.

David Gomez-Almaguer, Manuel Solano-Genesta, MD, Olga Cantu-Rodriguez, MD, Cesar Homero Gutierrez-Aguilar, MD, Jose Carlos Jaime-Perez, MD, Luz Carmen Tarin-Arzaga, MD, Miguel Angel Gomez-Guijosa, MD

Blood (2009) 114 (22): 4458.

https://doi.org/10.1182/blood.V114.22.4458.4458

Published: 2009

NARROW

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

Low Dose Rituximab and Plasma Exchange As Frontline Therapy for Patients with Thrombotic Thrombocytopenic Purpura

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Eltrombopag and High-Dose Dexamethasone As First Line Treatment For ITP

Prevalence Of FLT3 Mutations In Acute Myeloid Leukemia: A Multicenter Latin America Study

Low-Dose Nilotinib and Imatinib Combination In CML Patients, With Failure, Suboptimal Response Or Treatment Intolerance To First Line Imatinib Treatment. A Pilot Study

Alemtuzumab and Rituximab in the treatment of refractory autoimmune Cytopenias.

Email alerts

ASH Publications

American Society of Hematology

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

Low Dose Rituximab and Plasma Exchange As Frontline Therapy for Patients with Thrombotic Thrombocytopenic Purpura

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Eltrombopag and High-Dose Dexamethasone As First Line Treatment For ITP

Prevalence Of FLT3 Mutations In Acute Myeloid Leukemia: A Multicenter Latin America Study

Low-Dose Nilotinib and Imatinib Combination In CML Patients, With Failure, Suboptimal Response Or Treatment Intolerance To First Line Imatinib Treatment. A Pilot Study

Alemtuzumab and Rituximab in the treatment of refractory autoimmune Cytopenias.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only